Works matching IS 11753277 AND DT 2020 AND VI 20 AND IP 5
Results: 13
Current Overview on Hypercoagulability in COVID-19.
- Published in:
- American Journal of Cardiovascular Drugs, 2020, v. 20, n. 5, p. 393, doi. 10.1007/s40256-020-00431-z
- By:
- Publication type:
- Article
Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
- Published in:
- American Journal of Cardiovascular Drugs, 2020, v. 20, n. 5, p. 413, doi. 10.1007/s40256-020-00429-7
- By:
- Publication type:
- Article
Author's Reply to Peverill: "Predictors of Left Ventricular Dysfunction in Friedreich's Ataxia in a 16-Year Observational Study".
- Published in:
- 2020
- By:
- Publication type:
- Letter
Effects of Blood Pressure Lowering Agents on Cardiovascular Outcomes in Weight Excess Patients: A Systematic Review and Meta-analysis.
- Published in:
- American Journal of Cardiovascular Drugs, 2020, v. 20, n. 5, p. 447, doi. 10.1007/s40256-019-00393-x
- By:
- Publication type:
- Article
Comment on: "Predictors of Left Ventricular Dysfunction in Friedreich Ataxia in a 16-Year Observational Study".
- Published in:
- 2020
- By:
- Publication type:
- Letter
Comment on: Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Pharmacologic Management of Gout in Patients with Cardiovascular Disease and Heart Failure.
- Published in:
- American Journal of Cardiovascular Drugs, 2020, v. 20, n. 5, p. 431, doi. 10.1007/s40256-020-00400-6
- By:
- Publication type:
- Article
Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention.
- Published in:
- American Journal of Cardiovascular Drugs, 2020, v. 20, n. 5, p. 419, doi. 10.1007/s40256-020-00397-y
- By:
- Publication type:
- Article
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alirocumab in Healthy Chinese Subjects: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study.
- Published in:
- American Journal of Cardiovascular Drugs, 2020, v. 20, n. 5, p. 489, doi. 10.1007/s40256-020-00394-1
- By:
- Publication type:
- Article
Author's Reply to Vaz et al.: "Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease".
- Published in:
- 2020
- By:
- Publication type:
- Letter
Statins, LDL Cholesterol Control, Cardiovascular Disease Prevention, and Atherosclerosis Progression: A Clinical Perspective.
- Published in:
- American Journal of Cardiovascular Drugs, 2020, v. 20, n. 5, p. 405, doi. 10.1007/s40256-019-00391-z
- By:
- Publication type:
- Article
Effectiveness and Safety of Restarting Oral Anticoagulation in Patients with Atrial Fibrillation after an Intracranial Hemorrhage: Analysis of Medicare Part D Claims Data from 2010–2016.
- Published in:
- American Journal of Cardiovascular Drugs, 2020, v. 20, n. 5, p. 471, doi. 10.1007/s40256-019-00388-8
- By:
- Publication type:
- Article
Evolution of Patients with Pulmonary Arterial Hypertension Starting Macitentan After the Discontinuation of Other Endothelin-Receptor Antagonists: Results of a Retrospective Study.
- Published in:
- American Journal of Cardiovascular Drugs, 2020, v. 20, n. 5, p. 481, doi. 10.1007/s40256-019-00392-y
- By:
- Publication type:
- Article